New Strategies and Considerations for Your Clinical Management Playbook

Specialty spend is estimated to reach close to 50% by the end of 2020 – a trend that is expected to continue given manufacturers continued to focus on developing new drugs to treat rare conditions. As new specialty drugs are approved and come to market, high price tags will continue to shine a light on the need for proactive pharmacy benefits management. Now is the time to review and update your clinical playbook so that you are prepared to tackle the range of budget- and care-related challenges your self-funded clients are facing.

In this webinar, we’ll discuss how to help your clients create a tailored clinical strategy that achieves the best clinical outcomes and the lowest costs. You’ll learn why visibility into your clients’ pharmacy benefits plan performance is essential and how that data is used to craft strategies that can address both the current and future challenges facing your clients.

Presented By

Mark Campbell, PharmD Chief Pharmacy Officer

Emily Bell, PharmD Clinical Pharmacy Consultant

Langley Kyle RXBenefits Headshot

Langley Kyle, PharmD Clinical Pharmacy Consultant

Enjoy our latest blogs, white papers and news by signing up for our newsletter today!